TY - JOUR
T1 - Prevention of colonization and infection by klebsiella pneumoniae carbapenemase-producing enterobacteriaceae in long-term acute-care hospitals
AU - Hayden, Mary K.
AU - Lin, Michael Y.
AU - Lolans, Karen
AU - Weiner, Shayna
AU - Blom, Donald
AU - Moore, Nicholas M.
AU - Fogg, Louis
AU - Henry, David
AU - Lyles, Rosie
AU - Thurlow, Caroline
AU - Sikka, Monica
AU - Hines, David
AU - Weinstein, Robert A.
N1 - Funding Information:
Financial support. This work was supported by the Centers for Disease Control and Prevention (grant numbers U54CK000161 to R. A. W. and 200-2011-M-41103 to M. K. H.) and by an unrestricted gift from the Foglia Family Foundation to R. A. W. Sage Products, Inc, provided CHG-impregnated cloths to participating LTACHs at no cost.
Publisher Copyright:
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America.
PY - 2015/4/15
Y1 - 2015/4/15
N2 - Background. Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae (hereafter "KPC") are an increasing threat to healthcare institutions. Long-term acute-care hospitals (LTACHs) have especially high prevalence of KPC. Methods. Using a stepped-wedge design, we tested whether a bundled intervention (screening patients for KPC rectal colonization upon admission and every other week; contact isolation and geographic separation of KPC-positive patients in ward cohorts or single rooms; bathing all patients daily with chlorhexidine gluconate; and healthcare-worker education and adherence monitoring) would reduce colonization and infection due to KPC in 4 LTACHs with high endemic KPC prevalence. The study was conducted between 1 February 2010 and 30 June 2013; 3894 patients were enrolled during the preintervention period (lasting from 16 to 29 months), and 2951 patients were enrolled during the intervention period (lasting from 12 to 19 months). Results. KPC colonization prevalence was stable during preintervention (average, 45.8%; 95% confidence interval [CI], 42.1%-49.5%), declined early during intervention, then reached a plateau (34.3%; 95% CI, 32.4%-36.2%; P <.001 for exponential decline). During intervention, KPC admission prevalence remained high (average, 20.6%, 95% CI, 19.1%-22.3%). The incidence rate of KPC colonization fell during intervention, from 4 to 2 acquisitions per 100 patient-weeks (P =.004 for linear decline). Compared to preintervention, average rates of clinical outcomes declined during intervention: KPC in any clinical culture (3.7 to 2.5/1000 patient-days; P =.001), KPC bacteremia (0.9 to 0.4/1000 patient-days; P =.008), all-cause bacteremia (11.2 to 7.6/1000 patient-days; P =.006) and blood culture contamination (4.9 to 2.3/1000 patient-days; P =.03). Conclusions. A bundled intervention was associated with clinically important and statistically significant reductions in KPC colonization, KPC infection, all-cause bacteremia, and blood culture contamination in a high-risk LTACH population.
AB - Background. Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae (hereafter "KPC") are an increasing threat to healthcare institutions. Long-term acute-care hospitals (LTACHs) have especially high prevalence of KPC. Methods. Using a stepped-wedge design, we tested whether a bundled intervention (screening patients for KPC rectal colonization upon admission and every other week; contact isolation and geographic separation of KPC-positive patients in ward cohorts or single rooms; bathing all patients daily with chlorhexidine gluconate; and healthcare-worker education and adherence monitoring) would reduce colonization and infection due to KPC in 4 LTACHs with high endemic KPC prevalence. The study was conducted between 1 February 2010 and 30 June 2013; 3894 patients were enrolled during the preintervention period (lasting from 16 to 29 months), and 2951 patients were enrolled during the intervention period (lasting from 12 to 19 months). Results. KPC colonization prevalence was stable during preintervention (average, 45.8%; 95% confidence interval [CI], 42.1%-49.5%), declined early during intervention, then reached a plateau (34.3%; 95% CI, 32.4%-36.2%; P <.001 for exponential decline). During intervention, KPC admission prevalence remained high (average, 20.6%, 95% CI, 19.1%-22.3%). The incidence rate of KPC colonization fell during intervention, from 4 to 2 acquisitions per 100 patient-weeks (P =.004 for linear decline). Compared to preintervention, average rates of clinical outcomes declined during intervention: KPC in any clinical culture (3.7 to 2.5/1000 patient-days; P =.001), KPC bacteremia (0.9 to 0.4/1000 patient-days; P =.008), all-cause bacteremia (11.2 to 7.6/1000 patient-days; P =.006) and blood culture contamination (4.9 to 2.3/1000 patient-days; P =.03). Conclusions. A bundled intervention was associated with clinically important and statistically significant reductions in KPC colonization, KPC infection, all-cause bacteremia, and blood culture contamination in a high-risk LTACH population.
KW - Klebsiella pneumoniae carbapenemase
KW - carbapenem-resistant Enterobacteriaceae
KW - healthcare-associated infection
KW - infection prevention
KW - long-term acute-care hospital
UR - http://www.scopus.com/inward/record.url?scp=84926666022&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84926666022&partnerID=8YFLogxK
U2 - 10.1093/cid/ciu1173
DO - 10.1093/cid/ciu1173
M3 - Article
C2 - 25537877
AN - SCOPUS:84926666022
SN - 1058-4838
VL - 60
SP - 1154
EP - 1161
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 8
ER -